Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide ...

Maguire is a professor of neuroscience at Tufts University School of Medicine. Osborne is an associate professor of obstetrics and gynecology and psychiatry and a reproductive psychiatrist at ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The White House says Trump’s recent executive order is aimed at restoring trust in vaccines. It will do the opposite, writes an epidemiologist.

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Definium Therapeutics said Wednesday that ...

It's no mystery. History tells us that President Trump’s executive order calling for the MMR to be split into separate shots could do real harm.

Not long after guidelines shifted to considering statin therapy as early as age 30, new research from France suggests there may be no harm in stopping the cholesterol-lowering drugs at age 75 in ...

President Donald Trump’s administration said that Medicaid will stop paying for gender-affirming surgeries and hormone treatments for transgender minors and the state Children’s Health Insurance ...

On Monday, Trump signed an order that sought to unilaterally change the federal government’s approach to vaccinating children: recommending fewer shots, spreading them over longer periods, and doing ...

Sen. Bill Cassidy (R-La.) is not happy with Trump’s call for the MMR shot to be broken up. If only there had been a way to stop that. Send news tips and your biggest regrets to John.Wilkerson@statnews ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...